PT1159965E - Utilizacao de um antagonista do receptor da progesterona para a prevencao ou inibicao da fertilizacao - Google Patents

Utilizacao de um antagonista do receptor da progesterona para a prevencao ou inibicao da fertilizacao

Info

Publication number
PT1159965E
PT1159965E PT01117955T PT01117955T PT1159965E PT 1159965 E PT1159965 E PT 1159965E PT 01117955 T PT01117955 T PT 01117955T PT 01117955 T PT01117955 T PT 01117955T PT 1159965 E PT1159965 E PT 1159965E
Authority
PT
Portugal
Prior art keywords
receptor antagonist
progesterone receptor
fertilization
inhibition
prevention
Prior art date
Application number
PT01117955T
Other languages
English (en)
Inventor
Gary D Hodgen
Original Assignee
Eastern Virginia Med School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Med School filed Critical Eastern Virginia Med School
Publication of PT1159965E publication Critical patent/PT1159965E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Fertilizers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PT01117955T 1993-02-19 1994-02-18 Utilizacao de um antagonista do receptor da progesterona para a prevencao ou inibicao da fertilizacao PT1159965E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization

Publications (1)

Publication Number Publication Date
PT1159965E true PT1159965E (pt) 2005-03-31

Family

ID=21795040

Family Applications (2)

Application Number Title Priority Date Filing Date
PT01117955T PT1159965E (pt) 1993-02-19 1994-02-18 Utilizacao de um antagonista do receptor da progesterona para a prevencao ou inibicao da fertilizacao
PT94910707T PT684825E (pt) 1993-02-19 1994-02-18 Kit para a prevencao ou inibicao da fertilizacao

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT94910707T PT684825E (pt) 1993-02-19 1994-02-18 Kit para a prevencao ou inibicao da fertilizacao

Country Status (24)

Country Link
US (1) US5516769A (pt)
EP (2) EP1159965B1 (pt)
JP (1) JP3054780B2 (pt)
KR (1) KR100232833B1 (pt)
AT (2) ATE218347T1 (pt)
AU (1) AU692150B2 (pt)
BG (1) BG62431B1 (pt)
BR (1) BR9406666A (pt)
CA (1) CA2156493C (pt)
CZ (1) CZ294325B6 (pt)
DE (2) DE69430732T2 (pt)
DK (2) DK0684825T3 (pt)
ES (1) ES2231356T3 (pt)
FI (1) FI114687B (pt)
HU (1) HU221162B1 (pt)
NO (1) NO307916B1 (pt)
NZ (1) NZ262998A (pt)
PL (1) PL175440B1 (pt)
PT (2) PT1159965E (pt)
RO (1) RO118565B1 (pt)
RU (1) RU2139055C1 (pt)
SK (1) SK282068B6 (pt)
UA (1) UA41351C2 (pt)
WO (1) WO1994018982A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
AU781835B2 (en) 1999-08-31 2005-06-16 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
WO1994018982A1 (en) 1994-09-01
BR9406666A (pt) 1996-01-23
EP1159965A2 (en) 2001-12-05
DE69430732T2 (de) 2002-10-24
HU221162B1 (en) 2002-08-28
DK1159965T3 (da) 2005-05-23
EP1159965B1 (en) 2005-01-12
AU692150B2 (en) 1998-06-04
SK282068B6 (sk) 2001-10-08
BG62431B1 (bg) 1999-11-30
DE69430732D1 (de) 2002-07-11
US5516769A (en) 1996-05-14
BG99867A (bg) 1996-04-30
KR100232833B1 (ko) 1999-12-01
RU2139055C1 (ru) 1999-10-10
CZ205095A3 (en) 1996-01-17
ATE218347T1 (de) 2002-06-15
CA2156493C (en) 2002-10-29
SK101395A3 (en) 1997-04-09
RO118565B1 (ro) 2003-07-30
ES2231356T3 (es) 2005-05-16
NZ262998A (en) 1997-06-24
JP3054780B2 (ja) 2000-06-19
DK0684825T3 (da) 2002-07-15
PL175440B1 (pl) 1998-12-31
FI953878A0 (fi) 1995-08-17
EP0684825B1 (en) 2002-06-05
KR960700726A (ko) 1996-02-24
NO307916B1 (no) 2000-06-19
NO953242D0 (no) 1995-08-17
EP0684825A1 (en) 1995-12-06
EP1159965A3 (en) 2002-05-22
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
HUT72079A (en) 1996-03-28
FI953878A (fi) 1995-08-17
EP0684825A4 (en) 1998-01-14
ATE286734T1 (de) 2005-01-15
CA2156493A1 (en) 1994-09-01
JPH08510992A (ja) 1996-11-19
PL310357A1 (en) 1995-12-11
PT684825E (pt) 2002-10-31
NO953242L (no) 1995-08-17
CZ294325B6 (cs) 2004-11-10
UA41351C2 (uk) 2001-09-17
FI114687B (fi) 2004-12-15
AU6299294A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
PT735882E (pt) Combinacao contraceptiva contendo antagonistas de progesterona e um progestogeno
FR2656521B1 (fr) Procede et dispositif pour melanger et administrer directement au point d'application un ciment osseux constitue de deux composes.
ES2114605T3 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
BR9814435A (pt) Novos esteróides antiestrogênicos e composições farmacêuticas associadas
PT687251E (pt) Derivados de 1,3-di-hidro-indol-2-ona, substituidos na posicao 3 por um grupo azoto , como agonistas ou antagonistas da vasopressina e/ou ocitocina
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
NZ323456A (en) Pharmaceutical composition of an estrogen agonist/antagonist and a prostaglandin or a prostaglandin agonist/antagonist; useful for combination therapy for osteoporosis
NO921835D0 (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
FR2698261B1 (fr) Dispositif de guidage d'une double vis du col du fémur pour clou trochantéro-diaphysaire verrouillé.
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
ES2105501T3 (es) Unidades de dosificacion farmaceuticas revestidas de azucar.
ES2148329T3 (es) Antagonistas del receptor de fibrinogeno.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
PT1159965E (pt) Utilizacao de um antagonista do receptor da progesterona para a prevencao ou inibicao da fertilizacao
EP0467365A3 (en) Use of a 5-hydroxytryptamine-3(5-ht3) receptor antagonist for the preparation of a pharmaceutical composition for treating urinary incontinence
IT1273528B (it) Agonisti del recettore a3 della adenosina e composizioni farmaceutiche che li contengono
IT1246790B (it) Composizioni farmaceutiche per il trattamento del morbo di parkinson
ES2106683A1 (es) Derivados de 1,3-dioxoperhidropirido (1,2-c) pirimidinas como antagonistas de colecistoquinina.
MX9703018A (es) Antagonistas de progesterona competentes para regular la fertilidad femenina segun se requiera.
IT1269545B (it) Derivati idantoinici
FR2729569B1 (fr) Compositions pharmaceutiques utiles pour la reversion de la resistance multiple aux drogues